Abnormalities in  14 CO 2  production from DL-3,4-dihydroxyphenylalanine-carboxyl- 14 C in schizophrenia and parkinsonism: a preliminary report.
D002245:Carbon Dioxide / Q000097:blood*; D002247:Carbon Isotopes; D002478:Cells, Cultured; D003072:Cognition Disorders / Q000150:complications; D003653:Decarboxylation; D004295:Dihydroxyphenylalanine / Q000378:metabolism* / Q000627:therapeutic use; D004912:Erythrocytes / Q000378:metabolism; D006212:Hallucinations / Q000150:complications; D006801:Humans; D008722:Methods; D010300:Parkinson Disease / Q000097:blood / Q000188:drug therapy / Q000378:metabolism*; D012559:Schizophrenia / Q000097:blood / Q000150:complications / Q000378:metabolism*
D002247:Carbon Isotopes; D002245:Carbon Dioxide; D004295:Dihydroxyphenylalanine